SCHEMBL16448802

SCHEMBL16448802

CC/C=C/CCCOC(C)C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 4/20 0.40
LPAR2 Q9HBW0 3/20 0.40
LPAR1 Q92633 1/20 0.40
ADORA3 P0DMS8 2/20 0.39
NR1I2 O75469 2/20 0.39
PTGS2 P35354 2/20 0.39
PGR P06401 1/20 0.39
PDE4D Q08499 1/20 0.39
ALDH1A1 P00352 5/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
CYP3A4 P08684 2/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
TSHR P16473 1/20 0.37
F7 P08709 3/20 0.35
F3 P13726 3/20 0.35
CYP19A1 P11511 2/20 0.35
PTGS1 P23219 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16902073 0.86 ALDH1A1 (0.51) LPAR3LPAR2LPAR1NR1I2PTGS2
SCHEMBL16902072 0.86 LPAR2 (0.34) LPAR3LPAR2LPAR1ALDH1A1CYP19A1
SCHEMBL16902064 0.86 LPAR2 (0.34) LPAR3LPAR2LPAR1ALDH1A1CYP19A1
SCHEMBL28798179 0.81 ALDH1A1 (0.44) LPAR3LPAR2LPAR1ALDH1A1CNR1
SCHEMBL26001345 0.80 LPAR2 (0.47) LPAR3LPAR2LPAR1NR1I2PTGS2
SCHEMBL13864278 0.80 ALDH1A1 (0.33) ALDH1A1CNR1CNR2
SCHEMBL11856333 0.78 ALDH1A1 (0.56) LPAR3LPAR2LPAR1ALDH1A1CNR1
SCHEMBL16902067 0.78 ALDH1A1 (0.56) LPAR3LPAR2LPAR1ALDH1A1CNR1
SCHEMBL18134817 0.78 ALDH1A1 (0.56) LPAR3LPAR2LPAR1ALDH1A1CNR1
SCHEMBL11856338 0.78 ALDH1A1 (0.56) LPAR3LPAR2LPAR1ALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951998-B2 Quinoxaline-containing compounds as hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2015-02-10 US disclosed